KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $685.0 million.

  • Amgen's Interest Expenses fell 1172.68% to $685.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year decrease of 1176.83%. This contributed to the annual value of $3.2 billion for FY2024, which is 973.91% up from last year.
  • According to the latest figures from Q3 2025, Amgen's Interest Expenses is $685.0 million, which was down 1172.68% from $694.0 million recorded in Q2 2025.
  • Amgen's 5-year Interest Expenses high stood at $824.0 million for Q1 2024, and its period low was $281.0 million during Q2 2021.
  • Over the past 5 years, Amgen's median Interest Expenses value was $685.0 million (recorded in 2025), while the average stood at $565.0 million.
  • In the last 5 years, Amgen's Interest Expenses crashed by 1763.01% in 2021 and then soared by 12926.83% in 2023.
  • Amgen's Interest Expenses (Quarter) stood at $335.0 million in 2021, then rose by 23.88% to $415.0 million in 2022, then skyrocketed by 97.83% to $821.0 million in 2023, then decreased by 9.01% to $747.0 million in 2024, then dropped by 8.3% to $685.0 million in 2025.
  • Its Interest Expenses stands at $685.0 million for Q3 2025, versus $694.0 million for Q2 2025 and $723.0 million for Q1 2025.